Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/antiplatelet-agents-for-the-prevention-of-cardiovascular-disease-in-0PInPN50m9
References (138)
-
(1998)
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapyN Engl J Med, 339
-
J. Watanabe, H. Wohltmann, R. Klein, J. Colwell, M. Lopes-Virella (1988)
Enhancement of Platelet Aggregation by Low-Density Lipoproteins From IDDM PatientsDiabetes, 37
-
R. Klein, J. Colwell (1996)
Altered Endothelial Function in Diabetes Mellitus -
M. Goligorsky, Jun Chen, S. Brodsky (2001)
Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric OxideHypertension: Journal of the American Heart Association, 37
-
H. Krumholz, Ya-ting Chen, Yongfei Wang, M. Radford (2001)
Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction.Archives of internal medicine, 161 4
-
P. Sanmuganathan, P. Ghahramani, P. Jackson, E. Wallis, L. Ramsay (2001)
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsHeart, 85
-
S. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, M. Laakso (1998)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.The New England journal of medicine, 339 4
-
M. Davies (1996)
Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.Circulation, 94 8
-
横山 光宏, R. Ross (1998)
Atherosclerosis is an Inflammatory DiseaseJapanese Circulation Journal-english Edition, 62
-
M. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, I. Juhan-vague (1997)
Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular DiseaseDiabetes, 46
-
H. Leet, R. Paton, P. Passa, J. Caen (1981)
Fibrinogen binding and ADP-induced aggregation in platelets from diabetic subjects.Thrombosis research, 24 1-2
-
Rudolf Jokl, R. Klein, M. Lopes-Virella, J. Colwell (1995)
Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II DiabetesDiabetes Care, 18
-
H. Kwaan, J. Colwell, N. Suwanwela (1972)
Disseminated Intravascular Coagulation in Diabetes Mellitus, with Reference to the Role of Increased Platelet AggregationDiabetes, 21
-
J. Stamler, O. Vaccaro, J. Neaton, D. Wentworth (1993)
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 16
-
Yun Li, Vincent Woo, Ratna Bose (2001)
Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.American journal of physiology. Heart and circulatory physiology, 280 4
-
C. Patrono (1994)
Aspirin as an antiplatelet drug.The New England journal of medicine, 330 18
-
L. Hansson, A. Zanchetti, S. Carruthers, B. Dahlöf, D. Elmfeldt, S. Julius, J. Ménard, K. Rahn, H. Wedel, S. Westerling (1998)
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 351
-
D. Tschoepe, P. Roesen, J. Esser, B. Schwippert, H. Nieuwenhuis, B. Kehrel, F. Gries (1991)
Large Platelets Circulate in an Activated State in Diabetes MellitusSeminars in Thrombosis and Hemostasis, 17
-
(1992)
Aspirin effects on mortality and morbidity in prints with diabetes mellitusJAMA, 268
-
(1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetesLancet, 352
-
L. Kessler, M. Wiesel, P. Attali, J. Mossard, J. Cazenave, M. Pinget (1998)
Von Willebrand factor in diabetic angiopathy.Diabetes & metabolism, 24 4
-
M. Roncaglioni (2001)
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general PracticeThe Lancet, 357
-
J. Oates, A. Wood, G. FitzGerald (1987)
Drug therapy. DipyrimadoleThe New England Journal of Medicine, 316
-
K. Srivastava, D. Dash (2002)
Changes in membrane microenvironment and signal transduction in platelets from NIDDM patients-a pilot study.Clinica chimica acta; international journal of clinical chemistry, 317 1-2
-
Ken Gu, C. Cowie, M. Harris (1999)
Diabetes and decline in heart disease mortality in US adults.JAMA, 281 14
-
I. Juhan-vague, M. Alessi, P. Vague (1991)
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosisDiabetologia, 34
-
J. Colwell, R. Nair, P. Halushka, C. Rogers, A. Whetsell, J. Sagel (1979)
Platelet adhesion and aggregation in diabetes mellitus.Metabolism: clinical and experimental, 28 4 Suppl 1
-
M. Káplár, J. Kappelmayer, A. Veszprémi, K. Szábo, M. Udvardy (2001)
The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathyPlatelets, 12
-
T. Pearson, S. Blair, S. Daniels, R. Eckel, J. Fair, S. Fortmann, B. Franklin, L. Goldstein, P. Greenland, S. Grundy, Yuling Hong, N. Miller, R. Lauer, I. Ockene, R. Sacco, J. Sallis, Sidney Smith, N. Stone, K. Taubert (2002)
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.Circulation, 106 3
-
V. Fuster, J. Badimón, J. Chesebro, J. Fallon (1996)
Plaque rupture, thrombosis, and therapeutic implications.Haemostasis, 26 Suppl 4
-
D. Wood, W. Plehwe, P. Colman (1999)
Aspirin usage in a large teaching hospital diabetes clinic settingDiabetic Medicine, 16
-
R. Clarke, G. Mayo, P. Price, G. FitzGerald (1991)
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.The New England journal of medicine, 325 16
-
K. Sarji, H. Schraibman, A. Chambers, R. Nair, J. Colwell (1976)
Quantitative Studies of von Willebrand Factor (VWF) in Normal and Diabetic Subjects: Role of VWF in Second-Phase Platelet Aggregation -
S. Anand (2002)
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S. Circulation 2002; 105: 1650- 1655. -
A. Connor (2002)
The way I see it: House officers need formal career developmentBMJ, 324
-
J. Gonzalez, J. Colwell, K. Sarji, R. Nair, J. Sagel (1980)
Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.Thrombosis research, 17 1-2
-
C. Baigent, C. Sudlow, R. Collins, R. Peto, Antithromboci Collaborat (2002)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ : British Medical Journal, 324
-
J. Colwell (1997)
Aspirin Therapy in DiabetesDiabetes Care, 20
-
S. Krein, S. Vijan, L. Pogach, M. Hogan, E. Kerr (2002)
Aspirin use and counseling about aspirin among patients with diabetes.Diabetes care, 25 6
-
A. Ceriello (1997)
Fibrinogen and diabetes mellitus: is it time for intervention trials?Diabetologia, 40
-
R. Altman, L. Carreras, R. Diaz, E. Figueroa, E. Paolasso, J. Parodi, J. Cade, G. Donnan, M. Eadie, T. Gavaghan, E. OSullivan, D. Parkin, Renny Jtg., C. Silagy, H. Vinazzer, F. Zekert, H. Adriaensen, J. Bertrandhardy, M. Bran, J. David, J. Dricot, E. Lavennepardonge, R. Limet, A. Lowenthal, M. Moriau, S. Schapira, P. Smets, J. Symoens, R. Verhaeghe, M. Verstraete, A. Atallah, H. Barnett, R. Batista, J. Blakely, J. Cairns, R. Cote, J. Crouch, G. Evans, J. Findlay, M. Gent, Y. Langlois, J. Leclerc, J. Norris, G. Pineo, P. Powers, R. Roberts, L. Schwartz, J. Sicurella, W. Taylor, P. Théroux, A. Turpie, R. Weisel, J. Cui, L. Liu, J. Pirk, C. Bay, G. Boysen, J. Knudsen, P. Petersen, P. Sørensen, H. Tønnesen, P. Harjola, J. Arcan, B. Balkau, J. Blanchard, J. Boissel, B. Boneu, M. Bousser, M. Brochier, M. Cloarec, G. Cribier, M. Dechavanne, P. Drouin, E. Eschwège, B. Guiraudchaumeil, R. Hugonot, A. Leizorovicz, Y. Loria, L. Michat, J. Mirouze, E. Panak, J. Pasteyer, A. Rascol, L. Revol, M. Roy, J. Sellés, G. Slama, C. Starkman, M. Teule, N. Thibult, M. Verry, F. Albert, K. Andrassy, K. Breddin, R. Eckel, A. Encke, J. Frohlich, B. Hartung, H. Heiss, H. Hess, B. Hofling, D. Krause, G. Latta, H. Linke, D. Loew, R. Lorenz, K. Middleton, G. Novak, M. Oldendorf, N. Pfluger, D. Raithel, R. Reuter, G. Schettler, J. Schnitker, W. Schoop, H. Stiegler, K. Uberla, G. Vogel, M. Weber, I. Welbers, E. Zeitler, G. Arapakis, T. Chan, C. Mok, R. Szabó, N. Misra, K. Reddy, G. FitzGerald, A. Apollonio, F. Balsano, A. Basellini, L. Candelise, M. Catalano, N. Ciavarella, G. Ciuffetti, S. Coccheri, M. Cortellaro, G. Corvi, V. Coto, G. Davı̀, R. Decaterina, T. Diperri, C. Fieschi, R. Gentile, L. Gregoratti, P. Gresele, M. Lavezzari, A. Libretti, B. Magnani, Nenci Gg, G. Pagano, C. Patrono, L. Pedrini, M. Pini, P. Prandoni, F. Romeo, F. Rovelli, G. Rudelli, G. Ruvolo, G. Signorini, G. Tognoni, F. Violi, T. Fujimori, M. Kageyama, T. Katsumura, S. Kitamura, K. Maeda, A. Suzuki, H. Tohgi, S. Uchiyama, H. Utsumi, A. Garcia, A. Algra, Denottolander Gjh., Kupper Ajf., J. Vangijn, H. Hart, L. Kappelle, P. Koudstaal, T. Lemmens, J. Lodder, M. Pannebakker, P. Serruys, A. Vandenbelt, J. Vandermeer, A. Vandervijgh, Verheugt Fwa, G. Veth, J. Dale, K. Johannessen, E. Thaulow, P. Popescu, N. Tiberiu, Aznar Jrd., E. Esmatjes, P. Guiteras, J. Lasierra, P. Lopeztrigo, A. Oriol, L. Pomar, E. Rocha, F. Sanchez, J. Sanchorieger, G. Sanz, Berglund Ulf., C. Blomstrand, M. Boberg, M. Britton, C. Elwin, C. Helmers, J. Holm, L. Janzon, S. Juulmoller, H. Mulec, J. Olsson, S. Persson, G. Rasmanis, A. Rosén, K. Samuelsson, J. Soreff, N. Wahlgren, L. Wallentin, H. Baur, M. Bokslag, A. Bollinger, B. Meier, M. Pfisterer, C. Sitthiamorn, E. Acheson, P. Appleby, A. Asscher, A. Aukland, C. Baigent, S. Bala, A. Barnett, P. Bell, S. Bews, Born Gvr., J. Branagan, N. Brooks, M. Brown, N. Browse, R. Capildeo, M. Carmalt, A. Carter, I. Chalmers, M. Clarke, R. Clarke, Clyne Cac., R. Collins, Cooke, G. Coutts, D. Cove, P. Crowther, W. Cuthbertson, D. Debono, C. Dickerson, J. Dickinson, R. Doll, J. Dormandy, D. Dunbabin, S. Ell, P. Elphinstone, P. Elwood, V. Englishby, B. Farrell, C. Fiskerstrand, M. Flather, T. Foley, T. Foulds, K. Fox, P. Franks, H. Fraser, T. Gardecki, M. Gawel, A. Gent, A. Gershlick, J. Godwin, M. Goldman, C. Gray, D. Gray, R. Gray, H. Handoll, G. Hankey, Harrison Mjg., N. Henderson, S. Heptinstall, S. Hobbiger, E. Jones, Jones Nag., S. Jost, D. Julian, J. Kellett, R. Kester, G. Lowe, J. Mackenzie, C. McCollum, G. Mead, T. Meade, D. Mendelow, J. Miller, G. Morris, C. Nichol, M. Noble, Obrien, M. Ogier, S. Parish, M. Parry, R. Peto, J. Powell, P. Pozzilli, N. Qizilbash, A. Rahman, S. Rajah, D. Richards, S. Richards, R. Ripley, V. Roberts, F. Rose, Russell Rwr., P. Rubin, C. Ruckley, P. Sandercock, Shaw Mdm., K. Shaw, J. Shelley, J. Slattery, P. Sleight, S. Smith, P. Stewartlong, P. Sweetnam, Tansey Mjb., H. Tindall, J. Turney, H. Tyler, N. Varey, M. Vessey, M. Walker, M. Walker, C. Warlow, R. Wilcox, H. Willems, E. Wood, E. Wynjones, H. Adams, B. Barton, R. Bedford, B. Bick, S. Bingham, B. Brown, T. Bryant, J. Buring, C. Cabot, P. Canner, J. Chesebro, O. Chrisman, G. Clagett, J. Colwell, M. Dyken, D. Ellis, W. Fields, C. Furberg, V. Fuster, S. Goldman, J. Granett, R. Green, D. Green, R. Hardy, L. Harker, W. Harris, R. Hart, W. Hass, C. Hennekens, D. Hill, M. Hume, M. Igloe, G. Johnson, S. Jonas, G. Knatterud, T. Kohler, N. Lembo, D. Lewis, E. Lockhart, P. Majerus, Mcenany, R. McKenna, J. Mehta, J. Meyer, B. Molony, T. Moritz, D. Nicoloff, G. Nycz, H. Ono, G. Pantely, S. Phillips, P. Ridker, J. Robertson, R. Rothbart, E. Salzman, R. Sautter, R. Schlant, J. Schoenberger, M. Sengekontacket, G. Sharma, P. Steele, K. Steinnagel, J. Stratton, J. Sullivan, G. Timmis, J. Toole, Walker, S. Weisman, C. White, M. Wirecki, D. Wombolt, R. Wong, S. Yusuf, K. Zadina, D. Zucker (1994)
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 308
-
D.L. Bhatt, S.P. Marso, A.T. Hirsch (2000)
Superiority of clopidogrel versus aspirin in patients with a history of diabetes mellitus. [abstract]J Am Coll Cardiol, 35
-
R. Jokl, J.A. Colwell (1997)
International textbook of diabetes mellitus -
W. Hornsby, K. Boggess, T. Lyons, W. Barnwell, J. Lazarchick, J. Colwell (1990)
Hemostatic Alterations With Exercise Conditioning in NIDDMDiabetes Care, 13
-
P. Winocour, M. Laimins, J. Colwell (1984)
Platelet Survival in Streptozotocin-Induced Diabetic RatsThrombosis and Haemostasis, 51
-
Per Eriksson, S. Reynisdottir, F. Lönnqvist, V. Stemme, A. Hamsten, P. Arner (1998)
Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individualsDiabetologia, 41
-
A.J. Marcus (1983)
Editorial perspective: aspirin as an antithrombotic medicationN Engl J Med, 309
-
B. Wiman (1995)
Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma: Its Role in Thrombotic DiseaseThrombosis and Haemostasis, 74
-
S. Dabaghi, S. Kamat, J. Payne, G. Marks, R. Roberts, A. Schafer, N. Kleiman (1994)
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.The American journal of cardiology, 74 7
-
A. Stiko-Rahm, B. Wiman, A. Hamsten, J. Nilsson (1990)
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.Arteriosclerosis, 10 6
-
Teake Kooistra, P Bosma, H. Tons, A. Berg, Peter Meyer, Hans Princen (1989)
Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human HepatocytesThrombosis and Haemostasis, 62
-
H. Ostermann, J. Loo (1986)
Factors of the hemostatic system in diabetic patients. A survey of controlled studies.Haemostasis, 16 6
-
D. Tschoepe (1995)
The Activated Megakaryocyte-Platelet-System Vascular Disease: Focus on DiabetesSeminars in Thrombosis and Hemostasis, 21
-
(1998)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin or both in unstable angina: platelet IIb/IIIa antagonism for the reduction of acute coronary syndrome events in a global organization networkCirculation, 97
-
Dr. Ceriello (1993)
Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospectsDiabetologia, 36
-
(1989)
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy: a multicenter randomized controlled clinical trialDiabetes, 38
-
K.E. Sarji, J. Kleinfelder, P. Brewington (1979)
Decreased platelet vitamin C in diabetes mellitus: possible role in hyperaggregationThromb Res, 15
-
E. Bonifacio, C. Boitard, H. Gleichmann, M. Shattock, J. Molenaar, G. Bottazzo, S. Assa, A. Arnaiz-Villena, J. Barbosa, C. Betterle, E. Beutner, G. Bright, H. Chapel, M. Codina, R. Dawkins, E. Deitsch, U. Mario, G. Eisenbarth, R. Elliot, R. Bárbara, T. Hanafusa, L. Harrison, K. Helmke, C. Howard, P.In't Veld, D. Kawathara, T. Kobayashi, M. Landin, Å. Lernmark, N. Maclaren, T. Mandrup-Poulsen, R. Manna, A. Miettinen, J. Palmer, P. Pánczél, J. Peter, K. Pirich, L. Quenette, G. Reeves, K. Reinauer, W. Scherbaum, L. Scott-Morgan, D. Vergani, B. Vialettes (1990)
Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assaysDiabetologia, 33
-
R. Turner, C. Fox, Matthews, H. Mcelroy, C. Cull, R. Holman, P. Neil, D. Hadden, D. Wright, É. Manley, I. Stratton, Uk Diabetes, E. Kohner, Frighi, Michael Gnant (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.The Lancet
-
D. Nagi, J. Yudkin (1993)
Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 16
-
T. Ishibashi, Kenzo Tanaka, Y. Taniguchi (1981)
Platelet Aggregation and Coagulation in the Pathogenesis of Diabetic Retinopathy in RatsDiabetes, 30
-
P. Fattal, D. Schneider, B. Sobel, J. Billadello (1992)
Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.The Journal of biological chemistry, 267 18
-
D. Boeri, Michele Maiello, Mara Lorenzi (2001)
Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.Diabetes, 50 6
-
B. Coller (1985)
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.The Journal of clinical investigation, 76 1
-
D. Tschoepe, P. Roesen, L. Kaufmann, S. Schauseil, B. Kehrel, H. Ostermann, F. Gries (1990)
Evidence for abnormal platelet glycoprotein expression in diabetes mellitusEuropean Journal of Clinical Investigation, 20
-
P. Halushka, R. Rogers, C. Loadholt, J. Colwell (1981)
Increased platelet thromboxane synthesis in diabetes mellitus.The Journal of laboratory and clinical medicine, 97 1
-
(1998)
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction: platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptomsN Engl J Med, 338
-
J. Zile, M. Kilpatrick, M. Laimins, J. Sagel, J. Colwell, G. Virella (1981)
Platelet Aggregation and Release of ATP After Incubation with Soluble Immune Complexes Purified from the Serum of Diabetic PatientsDiabetes, 30
-
P. Tschoepe, L. Oresen, S. Kaufmann (1990)
Evidence for abnormal glycoprotein receptor expression on diabetic plateletsEur J Clin Invest, 20
-
R. Gray, D. Patterson, J. Yudkin (1993)
Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.Arteriosclerosis and thrombosis : a journal of vascular biology, 13 3
-
Bulent Mutus, R. Rabini, R. Staffolani, R. Ricciotti, P. Fumelli, N. Moretti, D. Martarelli, Laura Mazzanti (2001)
Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjectsDiabetologia, 44
-
P. Winocour, M. Lopes-Virella, M. Laimins, J. Colwell (1985)
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.The Journal of laboratory and clinical medicine, 106 3
-
P. Winocour, C. Watała, Raelene Kinglough-Rathbone (1992)
Membrane Fluidity Is Related to the Extent of Glycation of Proteins, but not to Alterations in the Cholesterol to Phospholipid Molar Ratio in Isolated Platelet Membranes from Diabetic and Control SubjectsThrombosis and Haemostasis, 67
-
M. Simoons (2001)
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trialThe Lancet, 357
-
F. Catella-Lawson, M. Reilly, S. Kapoor, A. Cucchiara, S. Demarco, B. Tournier, Sachin Vyas, G. FitzGerald (2001)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.The New England journal of medicine, 345 25
-
Deborah Rolka, A. Fagot-Campagna, Phd Narayan (2001)
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.Diabetes care, 24 2
-
J. Leor, H. Reicher-Reiss, U. Goldbourt, V. Boyko, S. Gottlieb, A. Battler, S. Behar (1999)
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.Journal of the American College of Cardiology, 33 7
-
E. Saltiel, A. Ward (1987)
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.Drugs, 34 2
-
(2002)
Clinical practice recommendationsDiabetes Care, 24
-
G. Davı̀, M. Belvedere, Sergio Vingneri, I. Catalano, C. Giammarresi, Salvatore Roccaforte, Agostino Consoil, A. Mezzetti (1996)
Influence of Metabolic Control on Thromboxane Biosynthesis and Plasma Plasminogen Activator Inhibitor Type-1 in Non-insulin-dependent Diabetes mellitusThrombosis and Haemostasis, 76
-
Antonio Ceriello, Dario Giugliano, A. Quatraro, Egidio Marchi, M. Barbanti, Pierre Lefebvre (1990)
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humansDiabetologia, 33
-
D. Clement (1996)
A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 348
-
D. Moliterno (2000)
Patient-specific dosing of IIb/IIIa antagonists during acute coronary syndromes: rationale and design of the PARAGON B study. The PARAGON B International Steering Committee.American heart journal, 139 4
-
D. Tschoepe, P. Roesen, B. Schwippert, F. Gries (1993)
Platelets in Diabetes: The Role in the Hemostatic Regulation in AtherosclerosisSeminars in Thrombosis and Hemostasis, 19
-
D. Mangano (2002)
Aspirin and mortality from coronary bypass surgery.The New England journal of medicine, 347 17
-
J. Eikelboom, J. Hirsh, J. Weitz, M. Johnston, Q. Yi, S. Yusuf (2002)
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation: Journal of the American Heart Association, 105
-
(1990)
Ticlopidine treatment reduces the progression of non-proliferative diabetic retinopathyArch Ophthalmol, 108
-
R.L. Klein, J.A. Colwell (1996)
Contemporary endocrinology: endocrinology of the vasculature -
(2002)
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 up dateCirculation, 106
-
J. Loscalzo (2001)
Nitric oxide insufficiency, platelet activation, and arterial thrombosis.Circulation research, 88 8
-
K. Sarji, J. Gonzalez, H. Hempling, J. Colwell (1979)
Decreased Platelet Vitamin C in Diabetes Mellitus; Possible Role in PeraggregatoonThrombosis and Haemostasis, 42
-
(1989)
Final report on the aspirin component of the ongoing Physicians Health StudyN Engl J Med, 321
-
S. Brodsky, A. Morrishow, Nimish Dharia, S. Gross, M. Goligorsky (2001)
Glucose scavenging of nitric oxide.American journal of physiology. Renal physiology, 280 3
-
D. Schneider, T. Nordt, B. Sobel (1992)
Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial CellsDiabetes, 41
-
T. Stys, W. Lawson, G. Smaldone, A. Styś (2000)
Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?Archives of internal medicine, 160 10
-
R. Assert, G. Scherk, A. Bumbure, V. Pīrāgs, H. Schatz, A. Pfeiffer (2001)
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitroDiabetologia, 44
-
G.A. Fitzgerald (1987)
DipyridamoleN Engl J Med, 316
-
D. Tschöpe, B. Schwippert, B. Schettler, U. Kiesel, H. Rothe, P. Roesen, F. Gries (1992)
Increased GPIIB/IIIA expression and altered DNA‐ploidy pattern in megakaryocytes of diabetic BB‐ratsEuropean Journal of Clinical Investigation, 22
-
I. Juhan-vague, C. Roul, M. Alessi, J. Ardissone, M. Heim, P. Vague (1989)
Increased Plasminogen Activator Inhibitor Activity in Non Insulin Dependent Diabetic Patients – Relationship with Plasma InsulinThrombosis and Haemostasis, 61
-
M. Bousser, E. Eschwège, M. Haguenau, J. Lefaucconnier, N. Thibult, D. Touboul, Touboul Pj (1983)
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.Stroke, 14 1
-
A. Sobol, C. Watała (2000)
The role of platelets in diabetes-related vascular complications.Diabetes research and clinical practice, 50 1
-
Rudolf Jokl, M. Laimins, R. Klein, T. Lyons, M. Lopes-Virella, J. Colwell (1994)
Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II DiabetesDiabetes Care, 17
-
E. Topol, Califf Rm, F. Werf, R. Diaz, E. Paolasso, P. Aylward, J. Simes, J. Col, L. Piegas, P. Armstrong, A. Langer, P. Grande, D. Debono, J. Heikkila, A. Vahanian, K. Neuhaus, W. Rutsch, P. Toutouzas, A. Kristinsson, D. Tzivoni, D. Ardissino, H. White, R. Seabra‐Gomes, A. Betriu, A. Dalby, H. Emanuelsson, M. Pfisterer, F. Verheugt, Z. Sadowski, E. Bates, W. Gibler, J. Gore, C. Granger, A. Guerci, Harrington Ra, J. Hochman, D. Holmes, N. Kleiman, D. Moliterno, D. Morris, E. Ohman, W. Weaver, K. Newby, S. Karnash, M. Peek-Hackenson, J. Mabie, J. Melton, J. Snapp, D. Brown, N. Dabolt, C. Greene, M. McClanahan, G. Strand, B. Tardiff, M. Winchell, J. Bolte, R. Evans, M. Poku, S. Conder, K. Tinnin, W. Lloyd, G. Jackson, Kerry Lee, M. Bhapkar, W. Sense, D. Passmore, L. Konczos, S. Caouette, S. Martin, W. Sutherland, A. Luyten, L. Tobback, K. Houbracken, R. Brower, L. D'hoore, A. Keech, M. Kava, R. Frye, M. Cheitlin, D. DeMets, L. Fisher, I. Jeffery, P. Taverner, W. Walsh, C. Friend, J. Leitch, K. Cox, B. Freedman, M. Gaynor, T. Campbell, S. D'arcy, D. Owensby, T. Davidson, D. Ramsey, W. Quinn, M. Verzosa, R. Wikramanayake, G. Manners, J. Waites, P. Cahill, J. Woods, A. Kearney, D. Fitzpatrick, D. Schoevers, D. Hunt, M. Sallaberger, J. Federman, H. Briggs, A. Appelbe, Michael Miller, R. Newman, C. Peeler, J. Lefkovits, L. Roberts, J. Counsell, M. Martin, A. Soward, J. Breeding, A. Tonkin, Lisa Brown, D. Cross, L. Fitzpatrick, P. Garrahy, C. Hall, C. Gnanaharan, C. Armstrong, P. Carroll, M. Duroux, C. Lim, B. Cooke, S. Coverdale, L. Joy, D. O’Brien, G. Aroney, P. Hicks, L. Arnolder, J. Horowitz, S. Lesley, S. Stewart, P. Thompson, P. Bradshaw, R. Henicks, J. Garrett, Bramahn Singh, M. Decampo, G. Świątecka, W. Piwowarska, P. Tadeusz, E. Nartowics, T. Kraska, L. Giec, A. Dyduszyński, J. Stepinska, J. Gorski, Kj Zdzislawa, E. Częstochowska, J. Kazimierz, M. Wierzchowiecki, A. Cieśliński, L. Ceremużyński, K. Loboz-grudzień, M. Krzeminska-Pakula, W. Krzysztof, Z. Wodniecki, C. Solal, F. Funck, M. Slama, T. Thanh, B. Vitoux, M. Halinen, Naukkarinen, J. Nurminen, E. Koskela, J. Melin, H. Koshivirta, H. Kivela, M. Rynen, A. Niemi, B. Dirk, F. Ottani, C. Vecchio, M. Orlandi, A. Capucci, A. Politi, F. Mauri, G. Rovelli, C. Montemartini, S. Vajola, A. Pezzano, A. Brusca, C. Vita, G. Pinelli, A. Branzi, S. Paolo, G. Ignone, G. Berni, F. Tartagni, C. Cernigliaro, F. Rusticali, G. Corsini, A. Polese, C. Morgan, K. Freskiw, S. MacRitchie, R. Sweeney, W. Tymchak, C. Kee, K. Finnie, M. McCreery, J. Heath, M. Thompson, M. Suavé, B. Szlachetka, Gebhardt, J. Taylor, W. Cameron, C. Noseworthy, F. Ervin, S. Leclair, W. Hui, L. Kvill, J. Mcdowell, R. Ziemski, D. Gossard, O. Magnon, G. Trembley, M. Senaratne, M. Goeres, S. Curley, P. Greenwood, A. Prosser, J. López, P. Kuny, W. Harrison, L. Maske, P. Ribeiro, Bishop, S. Raskin, J. Carr, M. Bushbinder, S. Koester, G. Gershony, B. Atherton-Pierce, O. Peller, P. Schofel, Joseph Smith, C. Sullivan, A. Chandler, M. Edwards, P. Gainey, S. Arsenaul, Richard White, S. Ham, T. Cheng, C. Monroe, R. Hahn, D. Quinn, D. Denny, T. Mccartney, R. Weiss, D. Thornton-Chandler, C. Martz, N. Niles, S. Kennedy, J. Goss, S. Goebel, R. Millar, K. Zolezzi, Z. Masúd, T. Giambra, C. Christie-Gulotta, N. Bhalodkar, A. Valeria, N. Juran, Akbar Shah, C. Edel, W. Leimbach, J. Durham, M. Kozak, H. Zimmerman, Peter Dibattiste, D. Poskus, J. Perry, W. Schvaneveldt, T. Nygaard, Jennifer White, G. Macdonald, S. Segel, K. Lehmann, M. Platt, Steven Singh, J. Sesing, W. Noble, D. Noble, H. Hart, H. Brannigan, D. Durham, R. Currie, R. Luke, D. Schmid, G. Lewis, M. Bent, B. Bruns, M. Liley, A. Morley, H. Patel, P. Leslie, K. Saunders, H. Iilram, T. Lawson, S. Mann, J. Dewar, D. Friedlander, L. Low, A. Hamer, J. Tomlinson, D. Jardine, P. Carstensen, G. Wilkins, M. Blok, M. Audeau, A. Smart, G. Chia, S. Megee, L. Bush, D. Hertzberger, R. Ciampricotti, P. Rossum, G. Lennep, H. Bonnier, B. Lutterman, A. Gomen, J. Engbers, P. Bernink, J. Chin, T. Loenhout, L. Wely, O. Perrino, E. Hasbani, J. Bono, A. Gambarte, J. Ramos, G. Zapata, J. García, C. Pellegrini, S. Simon, G. Covelli, Alejandro Barbagelata, Ea Sampo, G. Oddson, Jt Sverrisson, S. Chen, E. Kassis, K. Thygesen, J. Hansen, H. Madsen, E. Agner, Sl Rasmussen, T. Pindborg, P. Hildebrandt, H. Nielsen, D. Kikis, Hossmann, H. Ditter, I. Cyron, Oa Beck, I. Assmann, Ke Altmann, H. Nast, G. Muller-Esch, Kp Schusen, W. Kettner, H. Tillmanns, F. Althoff, B. Lüderitz, B. Maisch, H. Vohringer, C. Wissmann, D. Barchow, F. Schwerffener, J. Wagner, K. Zwirner, Gw Daniel, M. Kochs, R. Griebenow, H. Bolte, R. Matisonn, As Milha, A. Essop, Rm Jardine, M. Gebka, G. Cassel, D. Myburgh, F. Snyders, J. Bennett, S. Spilkin, T. Mabin, V. d'Almeida, Joan Gil, N. Pinheiro, L. Santos, L. Providência, J. Almeida, A. Ramos, Jc Santos, L. Inês, G. Silva, R. Ferreira, J. Leiria, M. Carrageta, A. Gonsalves, C. Ribeiro, M. Risenfors, L. Sandstedt, C. Adjorn, K. Christensen, J. Stephens, R. Northcote, M. Millar-Craig, A. Cance, D. Maciver, E. Rosen, R. Fernando, J. Nicolau, D. Carvalho (1998)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable anginaCirculation, 97
-
(1998)
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet receptor inhibition in ischemic syndrome managementN Engl J Med, 338
-
J. Gaspoz, P. Coxson, P. Goldman, L. Williams, K. Kuntz, M. Hunink, L. Goldman (2002)
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.The New England journal of medicine, 346 23
-
E. Falk, P. Shah, V. Fuster (1995)
Coronary plaque disruption.Circulation, 92 3
-
S. Yusuf, F. Zhao, S. Mehta, S. Chrolavicius, G. Tognoni, K. Fox, Clopidogrel Investigators (2001)
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.The New England journal of medicine, 345 7
-
P. Winocour, M. Lopes-Virella, M. Laimins, J. Colwell (1983)
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.The Journal of laboratory and clinical medicine, 102 5
-
(1991)
Effects of aspirin treatment on diabetic retinopathy: ETDRS report number 8Ophthalmology, 98
-
G. DiMinno, M. Silver, A. Cerbone, S. Murphy (1986)
Trial of repeated low-dose aspirin in diabetic angiopathy.Blood, 68 4
-
T.W. Meade, P.J. Brennan (2000)
on behalf of the MRC General Practice Research Framework. Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trialBMJ, 321
-
P. Sharis, C. Cannon, J. Loscalzo (1998)
The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 129
-
J. Vallés, M. Santos, J. Aznar, A. Osa, A. Lago, J. Cosín, E. Sánchez, M. Broekman, A. Marcus (1998)
Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.Circulation, 97 4
-
R. Fusman, R. Rotstein, K. Elishkewich, D. Zeltser, S. Cohen, M. Kofler, D. Avitzour, Nadir Arber, S. Berliner, I. Shapira (2001)
Image analysis for the detection of increased erythrocyte, leukocyte and platelet adhesiveness/aggregation in the peripheral blood of patients with diabetes mellitusActa Diabetologica, 38
-
M. Ellenberg, H. Rifkin (1970)
Diabetes mellitus: theory and practice -
D. Tschoepe, Elke Driesch, B. Schwippert, H. Nieuwenhuis, F. Gries (1995)
Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-NormoglycemiaDiabetes, 44
-
A. Vinik, T. Erbas, Tae Park, R. Nolan, G. Pittenger (2001)
Platelet dysfunction in type 2 diabetes.Diabetes care, 24 8
-
D. Tschoepe, U. Rauch, B. Schwippert (1997)
Platelet-leukocyte-cross-talk in diabetes mellitus.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 29 12
-
(2002)
Aspirin for the primary prevention of cardiovascular events: summary of the evidenceAnn Intern Med, 136
-
J. Callés-Escandon, S. Mirza, B. Sobel, D. Schneider (1998)
Induction of Hyperinsulinemia Combined With Hyperglycemia and Hypertriglyceridemia Increases Plasminogen Activator Inhibitor 1 in Blood in Normal Human SubjectsDiabetes, 47
-
D. Mills, R. Puri, Chang-Jun Hu, C. Minniti, G. Graña, M. Freedman, R. Colman, R. Colman (1992)
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and thrombosis : a journal of vascular biology, 12 4
-
A. Marcus (1983)
Aspirin as an antithrombotic medication.The New England journal of medicine, 309 24
-
A.I. Schafer (1996)
Antiplatelet therapyAm J Med, 101
-
M. Trovati, G. Anfossi (2002)
Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitusCurrent Diabetes Reports, 2
-
Nina Singh, Victor Yu (2002)
Prevention of Antibiotic Resistance in HospitalsAnnals of Internal Medicine, 136
-
M. Roffi, D. Chew, D. Mukherjee, Deepak Bhatt, J. White, C. Heeschen, C. Hamm, D. Moliterno, R. Califf, H. White, N. Kleiman, P. Théroux, E. Topol (2001)
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary SyndromesCirculation: Journal of the American Heart Association, 104
-
T. Meade, P. Brennan (2000)
Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trialBMJ : British Medical Journal, 321
-
S. Steinhubl, Peter Berger, J. III, Edward Fry, A. Delago, C. Wilmer, E. Topol (2002)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.JAMA, 288 19
-
A. Sima, S. Chakrabarti, R. Garcia-Salinas, P. Basu (1985)
The BB-rat--an authentic model of human diabetic retinopathy.Current eye research, 4 10
-
(2001)
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA, 285
-
J. Sagel, J. Colwell, L. Crook, M. Laimins (1975)
Increased platelet aggregation in early diabetus mellitus.Annals of internal medicine, 82 6
-
Steven M.D, Lawrence M.D (1995)
Novel antithrombotic therapeutics targeted against platelet glycoprotein IIb/IIIa.Annual review of medicine, 46
-
C. Watała, Magdalena Boncer, J. Golanski, W. Koziołkiewicz, Z. Trojanowski, B. Walkowiak (1998)
Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitusEuropean Journal of Haematology, 61
-
M. Dennis (1996)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeThe Lancet, 348
-
F. Ferris (1992)
Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.JAMA, 268 10
-
H. Kwaan, J. Colwell, J. Colwell, J. Colwell, S. Cruz, S. Cruz, S. Cruz, N. Suwanwela, N. Suwanwela, N. Suwanwela, Dobbie Jg, Dobbie Jg, Dobbie Jg (1972)
Increased platelet aggregation in diabetes mellitus.The Journal of laboratory and clinical medicine, 80 2
-
C.A. Cull, A. Neil, R.R. Holman (2002)
Changing aspirin use in UK patients with type 2 diabetesDiabetes, 51
-
J. Colwell, S. Bingham, C. Abraira, J. Anderson, J. Comstock, H. Kwaan, F. Nuttall (1986)
Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease RatesDiabetes Care, 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2004 by Adis Data Informotion BV
- Subject
- Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- DOI
- 10.2165/00129784-200404020-00003
- pmid
- 15049721
- Publisher site
- See Article on Publisher Site
Abstract
Patients with diabetes mellitus (DM) have accelerated atherothrombotic disease of coronary, cerebral, leg, and other vessels. The major cause of death is cardiovascular, and the risk for a myocardial infarction (MI) in a patient with DM who has never had a MI is the same as a nondiabetic individual who has already had one. In this paper, we review the major reasons for a prothrombotic state in patients with DM: alterations in the intrinsic coagulation and fibrinolytic systems and many abnormalities of platelet function. Increased platelet thromboxane production as well as activation of platelet receptors for fibrinogen and or adenosine diphosphate (ADP) are often present, and can be treated with aspirin (acetylsalicylic acid) and/or receptor blockers.
Journal
American Journal of Cardiovascular Drugs – Springer Journals
Published: Sep 11, 2012